Health Care Tech

“We don’t have all facts, so we don’t know the causation per se of this, but we really need to look into it," FDA Commissioner Stephen Hahn said.

While Bourla acknowledged the possibility Pfizer's vaccine candidate could fail, he argued that he doesn't believe any potential financial hit will "break the company" despite investing at least $1.5 billion in the effort.

Pfizer and BioNTech reiterated that results from their vaccine candidate's late-stage trial could be available as early as October.

Oxford University says trials of a coronavirus vaccine that it is developing with pharmaceutical company AstraZeneca will resume, days after being paused due to a reported side-effect in a patient in the U.K.

The International Air Transport Association is warning governments across the globe that the air cargo industry may potentially face severe capacity constraints that could hinder the timely distribution of a COVID-19 vaccine. 

AstraZeneca shares have plunged more than 7% in after-hours trading following news that the company's Phase 3 trial for its COVID-19 vaccine has been put on hold due to safety concerns.

Major COVID-19 vaccine developers are to release a joint statement this week vowing to prioritize safety before speed by waiting to seek emergency government approval for the vaccine until human trials show "substantial evidence of safety and efficacy," according to a report.

Serbia and Pakistan are among the new countries agreeing to Phase 3 trials, as the two companies seek more data overseas amid dwindling new cases in China.